Institutional Ownership
Acceleron Pharma Inc
CUSIP 00434H108COMMON STOCKXLRNQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Nov 24, 2021
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 24, 2021 | Avoro Capital Advisors LLC | 13D/A | — | — | SEC |
| 2 | Nov 10, 2021 | Fmr LLC | 13G/A | 0.8% | — | SEC |
| 3 | Oct 5, 2021 | Avoro Capital Advisors LLC | 13D | 7.3% | 4.48M | SEC |
| 4 | Feb 16, 2021 | Price T Rowe Associates Inc /Md/ | 13G/A | 8.8% | 5.31M | SEC |
| 5 | Feb 10, 2021 | Vanguard Group Inc | 13G/A | 8.3% | 5.03M | SEC |
| 6 | Feb 8, 2021 | Fmr LLC | 13G/A | 7.8% | — | SEC |
| 7 | Jan 29, 2021 | Blackrock Inc. | 13G/A | 7.7% | 4.61M | SEC |
| 8 | Sep 10, 2020 | Fmr LLC | 13G/A | 9.8% | — | SEC |
| 9 | Jul 16, 2020 | Bristol Myers Squibb Co | 13D/A | 12.0% | 7.01M | SEC |
| 10 | Jun 9, 2020 | Blackrock Inc. | 13G/A | 10.0% | 5.39M | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Acceleron Pharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 2 | $358 |